Loading clinical trials...
Loading clinical trials...
Evaluation of Non-small Cell Lung Carcinoma Genetic Heterogeneity in Patients With Operable Early Stage Disease and Prediction of Clinical Relapse Using a Personalized "Liquid Biopsy"
Conditions
Interventions
blood sampling
Locations
6
Greece
2nd Pneumological Dept, GNA "Sotiria"
Athens, Attica, Greece
7th Pneumological Dept, GNA "Sotiria"
Athens, Attica, Greece
Thoracic Surgery Dept, GNA "Sotiria"
Athens, Attica, Greece
Thoracic Surgery Clinic, "Hygeia" Hospital
Athens, Attica, Greece
Oncology Unit, 3rd Department of Medicine Athens University School of Medicine Athens, GNA "Sotiria"
Athens, Greece
IASO General Hospital
Athens, Greece
Start Date
January 5, 2018
Primary Completion Date
December 1, 2021
Completion Date
December 1, 2021
Last Updated
December 11, 2018
NCT06066138
NCT07485114
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
Hellenic Oncology Research Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions